Evergreen Nephrology Raises $130 Million to Transform and Expand Access to Value-Based Kidney Care

Jan 7

Evergreen Nephrology, a leader in value-based kidney care, today announced it has raised $130 million in capital to expand its care model to more patients living with kidney disease. Funding was led by Rubicon Founders, Oak HC/FT and a group of existing investors, with the addition of K2 HealthVentures. Funding will fuel Evergreen's growth by enabling its expansion into new regions while implementing advanced technologies to improve clinical outcomes, streamline care delivery, and ease the administrative burden on nephrologists.

Megan Prock McGrath

Evergreen Nephrology Raises $130 Million to Transform and Expand Access to Value-Based Kidney Care

Umoja Biopharma Announces Oversubscribed $100 Million Series C Financing to Advance In Vivo CAR T Pipeline through Key Oncology Clinical Milestones

Inari Raises $144 Million, Paving Path to Long-Term Growth